The C-glucosyl bond of puerarin was cleaved hydrolytically by a human intestinal bacterium strain PUE to yield its aglycone daidzein and an intact glucose

Chemical and Pharmaceutical Bulletin

Volumn 59, Issue 1, 2011, Pages 23-27

  Nakamura, Kenichi ^a,b   Nishihata, Tomohiro ^a   Jin, Jong Sik ^a   Ma, Chao Mei ^a   Komatsu, Katsuko ^a   Iwashima, Makoto ^b   Hattori, Masao ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

C glucoside; Human intestinal bacterium; Puerarin

Indexed keywords

[6',6' D2]PUERARIN; AGLYCONE; CARBOHYDRATE; DAIDZEIN; DEUTERIUM; DRUG METABOLITE; GLUCOSE; GLYCOSIDE; PUERARIN; PYRAZOLONE; SUGAR; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL STRAIN PUE; CHEMICAL BOND; CHEMICAL REACTION; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROGENATION; HYDROLYSIS; HYDROXYLATION; INTESTINE FLORA; NONHUMAN;

BACTERIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEUTERIUM; GLUCOSE; HUMANS; INTESTINES; ISOFLAVONES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 78650849540     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.59.23     Document Type: Article

References (17)

1. Jin J. S., Nishihata T., Kakiuchi N., Hattori M., Biol. Pharm. Bull., 31, 1621-1625 (2008).
2. Yang G., Schmieg J., Tsuji M., Franck R. W., Angew. Chem. Int. Ed., 43, 3818-3822 (2004).
3. Hattori M., Kanda T., Shu Y., Akao T., Kobashi K., Namba T., Chem. Pharm. Bull., 36, 4462-4466 (1988).
4. Hattori M., Shu Y., El-Sedawy A., Namba T., Kobashi K., Tomimori T., J. Nat. Prod., 51, 874-878 (1988).
5. Hattori M., Shu Y., Tomimori T., Kobashi K., Namba T., Phytochemistry, 28, 1289-1290 (1989).
6. Che Q., Akao T., Hattori M., Kobashi K., Namba T., Chem. Pharm. Bull., 39, 704-708 (1991).
7. Che Q., Akao T., Hattori M., Tsuda Y., Namba T., Kobashi K., Chem. Pharm. Bull., 39, 757-760 (1991).
8. Meselhy M. R., Kadota S., Hattori M., Namba T., J. Nat. Prod., 56, 39-45 (1993).
9. Li Y., Meselhy M. R., Wang L., Ma C., Nakamura N., Hattori M., Chem. Pharm. Bull., 48, 1239-1241 (2000).
10. Sanugul K., Akao T., Li Y., Kakiuchi N., Nakamura N., Hattori M., Biol. Pharm. Bull., 28, 1672-1678 (2005).
11. Sanugul K., Akao T., Nakamura N., Hattori M., Biol. Pharm. Bull., 28, 2035-2039 (2005).
12. Soai K., Oyamada H., Takase M., Ookawa A., Bull. Chem. Soc. Jpn., 57, 1948-1953 (1984).
13. Lamari F. N., Kuhn R., Karamanos N. K., J. Chrom. B, 793, 15-36 (2003).
14. Honda S., Akao E., Suzuki S., Okuda M., Kakehi K., Nakamura J., Anal. Biochem., 180, 351-357 (1989).
15. Bergmeyer H. U., "Methods of Enzymatic Analysis," 2nd English Edition, New York, Academic Press, 1974, pp. 1205-1212.
16. Pazur J. H., Methods Enzymol., 9, 82-87 (1966).
17. 13C-NMR were taken as a conformational mixture. The assignments of them were performed by gCOSY, gHSQC, gHMBC and gHSQC-TOCSY analysis.